SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-12-317099
Filing Date
2012-07-26
Accepted
2012-07-26 17:23:13
Documents
11
Period of Report
2012-06-30
Filing Date Changed
2012-07-26

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d358499d10q.htm 10-Q 900891
2 SECTION 302 CEO CERTIFICATION d358499dex311.htm EX-31.1 6711
3 SECTION 302 CFO CERTIFICATION d358499dex312.htm EX-31.2 6803
4 SECTION 906 CEO CERTIFICATION d358499dex321.htm EX-32.1 3651
5 SECTION 906 CFO CERTIFICATION d358499dex322.htm EX-32.2 3734
  Complete submission text file 0001193125-12-317099.txt   6739383

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT wpi-20120630.xml EX-101.INS 1061038
7 XBRL TAXONOMY EXTENSION SCHEMA wpi-20120630.xsd EX-101.SCH 51187
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wpi-20120630_cal.xml EX-101.CAL 84696
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wpi-20120630_def.xml EX-101.DEF 196766
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE wpi-20120630_lab.xml EX-101.LAB 414539
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wpi-20120630_pre.xml EX-101.PRE 300408
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
WATSON PHARMACEUTICALS INC (Filer) CIK: 0000884629 (see all company filings)

IRS No.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13305 | Film No.: 12988225
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1